Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$573M |
| 2 |
Verizon
VZ
|
+$503M |
| 3 |
Rio Tinto
RIO
|
+$272M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$243M |
| 5 |
Merck
MRK
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.04B |
| 2 |
ProShares Ultra S&P500
SSO
|
+$1.02B |
| 3 |
Apple
AAPL
|
+$813M |
| 4 |
Microsoft
MSFT
|
+$543M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$496M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.46% |
| 2 | Healthcare | 10.97% |
| 3 | Financials | 10.47% |
| 4 | Technology | 10.21% |
| 5 | Real Estate | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
BioCryst Pharmaceuticals
BCRX
$2.28B
| $985K | ﹤0.01% |
93,221
+72,448
| +349% | +$772K |
|
|
ITG
2727
DELISTED
Investment Technology Group Inc
ITG
| $985K | ﹤0.01% |
48,795
-85,182
| -64% | -$1.54M |
|
|
DBL
2728
DoubleLine Opportunistic Credit Fund
DBL
$278M
| $983K | ﹤0.01% |
42,475
+7,375
| +21% | +$170K |
|
2729
PennyMac Financial
PFSI
$3.92B
| $979K | ﹤0.01% |
58,847
+55,519
| +1,668% | +$967K |
|
2730
TriplePoint Venture Growth BDC
TPVG
$184M
| $979K | ﹤0.01% |
+60,334
| New | +$964K |
|
2731
IPG Photonics
IPGP
$3.61B
| $977K | ﹤0.01% |
13,749
+1,425
| +12% | +$100K |
|
|
SVA
2732
DELISTED
Sinovac Biotech, Ltd
SVA
| $977K | ﹤0.01% |
135,876
-49,071
| -27% | -$325K |
|
|
CMD
2733
DELISTED
Cantel Medical Corporation
CMD
| $976K | ﹤0.01% |
28,970
+7,294
| +34% | +$241K |
|
|
RXII
2734
DELISTED
GALENA BIOPHARMA INC COM
RXII
| $976K | ﹤0.01% |
390,785
+370,677
| +1,843% | +$926K |
|
|
CCXI
2735
DELISTED
ChemoCentryx, Inc.
CCXI
| $975K | ﹤0.01% |
147,158
+22,070
| +18% | +$153K |
|
2736
Barclays
BCS
$92.7B
| $972K | ﹤0.01% |
66,914
+44,328
| +196% | +$710K |
|
|
EGL
2737
DELISTED
Engility Holdings, Inc.
EGL
| $972K | ﹤0.01% |
21,648
+12,315
| +132% | +$506K |
|
|
HIBB
2738
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $970K | ﹤0.01% |
18,369
+18,189
| +10,105% | +$1.07M |
|
|
TLP
2739
DELISTED
Transmontaigne
TLP
| $965K | ﹤0.01% |
22,407
-8,680
| -28% | -$370K |
|
2740
City Holding Co
CHCO
$2.05B
| $963K | ﹤0.01% |
21,482
+7,867
| +58% | +$353K |
|
|
FRGI
2741
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $962K | ﹤0.01% |
21,140
+9,396
| +80% | +$442K |
|
2742
Innospec
IOSP
$2.12B
| $960K | ﹤0.01% |
21,256
+8,408
| +65% | +$371K |
|
|
DQ
2743
Daqo New Energy
DQ
$823M
| $959K | ﹤0.01% |
112,000
+49,500
| +79% | +$421K |
|
2744
Azenta
AZTA
$1.3B
| $958K | ﹤0.01% |
87,747
+12,172
| +16% | +$128K |
|
|
AVNR
2745
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $958K | ﹤0.01% |
261,202
+39,268
| +18% | +$150K |
|
2746
Gevo
GEVO
$360M
| $955K | ﹤0.01% |
136
+119
| +700% | +$939K |
|
2747
Invesco Dividend Achievers ETF
PFM
$791M
| $954K | ﹤0.01% |
47,517
-22,333
| -32% | -$437K |
|
2748
Empire State Realty Trust
ESRT
$872M
| $952K | ﹤0.01% |
63,097
-2,158
| -3% | -$32.1K |
|
2749
RLI Corp
RLI
$5.62B
| $951K | ﹤0.01% |
43,038
+1,130
| +3% | +$24.7K |
|
2750
Orthofix Medical
OFIX
$477M
| $950K | ﹤0.01% |
31,533
-91,160
| -74% | -$2.1M |
|
Similar funds
Deutsche Bank's Q1 2014 Portfolio in Review
As of Q1 2014, Deutsche Bank held 6,109 positions worth $141B, up 1.2% from $139B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Deutsche Bank's Q1 2014 filing shows 524 new, 2,784 increased, 1,757 reduced and 419 closed positions. Its largest new stake was Vale S A: 3,319,357 shares worth $41.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.04B.
By sector, the portfolio is most concentrated in Energy at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.
- Deutsche Bank's largest Q1 2014 buy was Vale S A: 3,319,357 shares worth $41.3M.
- Deutsche Bank added most to Invesco QQQ Trust in Q1 2014, an estimated $573M increase.
- Deutsche Bank's biggest Q1 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.04B.
- Deutsche Bank fully exited ProShares Ultra S&P500 in Q1 2014, selling an estimated $1.02B.
- Deutsche Bank's ten largest holdings make up 11% of its $141B portfolio in Q1 2014.
- Deutsche Bank opened 524 new positions and closed 419 in Q1 2014.
- Deutsche Bank's portfolio value rose 1.2% quarter-over-quarter to $141B.
Based on Deutsche Bank's 13F filing for Q1 2014, filed 15 May 2014.